Article
A recombinant virus assay using full-length envelope sequences to detect changes in HIV-1 co-receptor usage.
Virus genes - 1 Dec 2001
Dittmar M T, Eichler S, Reinberger S, Henning L, Kräusslich H G
Abstract excerpt
The clinical management of HIV-1 infection has benefited enormously from molecular characterization of drug resistance as well as determination of the viral phenotype in vitro. HIV-1 infected individuals on HAART are currently monitored for the development of drug resistance variants allowing clinicians to redesign drug regimens. An understanding of the molecular basis of the evolution of drug resistance in vivo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
